Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jögi J[au]:

Search results

Items: 38

1.

Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease.

Mattsson N, Insel PS, Donohue M, Jögi J, Ossenkoppele R, Olsson T, Schöll M, Smith R, Hansson O.

Alzheimers Dement. 2019 Apr;15(4):570-580. doi: 10.1016/j.jalz.2018.12.001. Epub 2019 Jan 25.

PMID:
30639421
2.

Qualitative assessments of myocardial ischemia by cardiac MRI and coronary stenosis by invasive coronary angiography in relation to quantitative perfusion by positron emission tomography in patients with known or suspected stable coronary artery disease.

Akil S, Hedeer F, Carlsson M, Arheden H, Oddstig J, Hindorf C, Jögi J, Erlinge D, Engblom H.

J Nucl Cardiol. 2018 Dec 10. doi: 10.1007/s12350-018-01555-1. [Epub ahead of print]

PMID:
30535919
3.

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, Palmqvist S, Mattsson N, Janelidze S, Santillo A, Ohlsson T, Jögi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O.

JAMA. 2018 Sep 18;320(11):1151-1162. doi: 10.1001/jama.2018.12917.

4.

Effect of exercise on the plasma vesicular proteome: a methodological study comparing acoustic trapping and centrifugation.

Bryl-Górecka P, Sathanoori R, Al-Mashat M, Olde B, Jögi J, Evander M, Laurell T, Erlinge D.

Lab Chip. 2018 Oct 9;18(20):3101-3111. doi: 10.1039/c8lc00686e.

PMID:
30178811
5.

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.

Mattsson N, Ossenkoppele R, Smith R, Strandberg O, Ohlsson T, Jögi J, Palmqvist S, Stomrud E, Hansson O.

Alzheimers Res Ther. 2018 Aug 7;10(1):77. doi: 10.1186/s13195-018-0403-x.

6.

The association between plasma miR-122-5p release pattern at admission and all-cause mortality or shock after out-of-hospital cardiac arrest.

Gilje P, Frydland M, Bro-Jeppesen J, Dankiewicz J, Friberg H, Rundgren M, Devaux Y, Stammet P, Al-Mashat M, Jögi J, Kjaergaard J, Hassager C, Erlinge D.

Biomarkers. 2019 Feb;24(1):29-35. doi: 10.1080/1354750X.2018.1499804. Epub 2018 Aug 23.

PMID:
30015516
7.

Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization.

Jögi J, Al-Mashat M, Rådegran G, Bajc M, Arheden H.

ESC Heart Fail. 2018 Oct;5(5):902-910. doi: 10.1002/ehf2.12317. Epub 2018 Jul 17.

8.

Differences in attenuation pattern in myocardial SPECT between CZT and conventional gamma cameras.

Oddstig J, Martinsson E, Jögi J, Engblom H, Hindorf C.

J Nucl Cardiol. 2018 May 23. doi: 10.1007/s12350-018-1296-6. [Epub ahead of print]

PMID:
29796975
9.

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.

Mattsson N, Smith R, Strandberg O, Palmqvist S, Schöll M, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Blennow K, Jögi J, Hansson O.

Neurology. 2018 Jan 30;90(5):e388-e395. doi: 10.1212/WNL.0000000000004887. Epub 2018 Jan 10.

10.

Automatic lung segmentation in functional SPECT images using active shape models trained on reference lung shapes from CT.

Cheimariotis GA, Al-Mashat M, Haris K, Aletras AH, Jögi J, Bajc M, Maglaveras N, Heiberg E.

Ann Nucl Med. 2018 Feb;32(2):94-104. doi: 10.1007/s12149-017-1223-y. Epub 2017 Dec 13.

11.

Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.

Schöll M, Ossenkoppele R, Strandberg O, Palmqvist S; Swedish BioFINDER study, Jögi J, Ohlsson T, Smith R, Hansson O.

Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.

PMID:
29050382
12.

In vivo retention of 18F-AV-1451 in corticobasal syndrome.

Smith R, Schöll M, Widner H, van Westen D, Svenningsson P, Hägerström D, Ohlsson T, Jögi J, Nilsson C, Hansson O.

Neurology. 2017 Aug 22;89(8):845-853. doi: 10.1212/WNL.0000000000004264. Epub 2017 Jul 28.

13.

Longitudinal shortening remains the principal component of left ventricular pumping in patients with chronic myocardial infarction even when the absolute atrioventricular plane displacement is decreased.

Asgeirsson D, Hedström E, Jögi J, Pahlm U, Steding-Ehrenborg K, Engblom H, Arheden H, Carlsson M.

BMC Cardiovasc Disord. 2017 Jul 28;17(1):208. doi: 10.1186/s12872-017-0641-z.

14.

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.

Mattsson N, Schöll M, Strandberg O, Smith R, Palmqvist S, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Jögi J, Blennow K, Hansson O.

EMBO Mol Med. 2017 Sep;9(9):1212-1223. doi: 10.15252/emmm.201707809.

15.

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks.

Hansson O, Grothe MJ, Strandberg TO, Ohlsson T, Hägerström D, Jögi J, Smith R, Schöll M.

Front Neurosci. 2017 Mar 31;11:167. doi: 10.3389/fnins.2017.00167. eCollection 2017.

16.

Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology.

Hahn A, Schain M, Erlandsson M, Sjölin P, James GM, Strandberg OT, Hägerström D, Lanzenberger R, Jögi J, Olsson TG, Smith R, Hansson O.

J Nucl Med. 2017 Apr;58(4):623-631. doi: 10.2967/jnumed.116.174508. Epub 2016 Oct 20.

17.

Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy.

Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, Hägerström D, Jögi J, Borroni E, Schöll M, Honer M, Hansson O.

Mov Disord. 2017 Jan;32(1):108-114. doi: 10.1002/mds.26813. Epub 2016 Oct 6.

18.

The radiation dose to overweighted patients undergoing myocardial perfusion SPECT can be significantly reduced: validation of a linear weight-adjusted activity administration protocol.

Oddstig J, Hindorf C, Hedeer F, Jögi J, Arheden H, Hansson MJ, Engblom H.

J Nucl Cardiol. 2017 Dec;24(6):1912-1921. doi: 10.1007/s12350-016-0628-7. Epub 2016 Aug 9.

PMID:
27506700
19.

Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.

Smith R, Wibom M, Olsson T, Hägerström D, Jögi J, Rabinovici GD, Hansson O.

J Alzheimers Dis. 2016;51(2):339-43. doi: 10.3233/JAD-151004.

PMID:
26836192
20.

V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism.

Bajc M, Olsson B, Gottsäter A, Hindorf C, Jögi J.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1325-30. doi: 10.1007/s00259-015-3056-z. Epub 2015 Apr 28.

21.

The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.

Jögi J, Markstad H, Tufvesson E, Bjermer L, Bajc M.

Int J Chron Obstruct Pulmon Dis. 2014 Dec 18;10:25-30. doi: 10.2147/COPD.S73423. eCollection 2015.

22.

Impact of ventilation/perfusion single-photon emission computed tomography on treatment duration of pulmonary embolism.

Begic A, Opanković E, Čukić V, Rustempašić M, Bašić A, Miniati M, Jögi J, Bajc M.

Nucl Med Commun. 2015 Feb;36(2):162-7. doi: 10.1097/MNM.0000000000000224.

23.

Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers.

Bajc M, Markstad H, Jarenbäck L, Tufvesson E, Bjermer L, Jögi J.

Ann Nucl Med. 2015 Jan;29(1):91-9. doi: 10.1007/s12149-014-0913-y. Epub 2014 Oct 15.

24.

Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.

Morgan AR, Parker GJ, Roberts C, Buonaccorsi GA, Maguire NC, Hubbard Cristinacce PL, Singh D, Vestbo J, Bjermer L, Jögi J, Taib Z, Sarv J, Bruijnzeel PL, Olsson LE, Bondesson E, Nihlén U, McGrath DM, Young SS, Waterton JC, Nordenmark LH.

Eur J Radiol. 2014 Nov;83(11):2093-101. doi: 10.1016/j.ejrad.2014.08.004. Epub 2014 Aug 17.

PMID:
25176287
25.

Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.

Gyllenhammar T, Fernlund E, Jablonowski R, Jögi J, Engblom H, Liuba P, Arheden H, Carlsson M.

Eur Heart J Cardiovasc Imaging. 2014 Dec;15(12):1350-7. doi: 10.1093/ehjci/jeu137. Epub 2014 Aug 19.

PMID:
25139907
26.

Home treatment of patients with small to medium sized acute pulmonary embolism.

Elf JE, Jögi J, Bajc M.

J Thromb Thrombolysis. 2015 Feb;39(2):166-72. doi: 10.1007/s11239-014-1097-y.

PMID:
24942995
27.

Importance of correct patient positioning in myocardial perfusion SPECT when using a CZT camera.

Hindorf C, Oddstig J, Hedeer F, Hansson MJ, Jögi J, Engblom H.

J Nucl Cardiol. 2014 Aug;21(4):695-702. doi: 10.1007/s12350-014-9897-1. Epub 2014 May 8.

PMID:
24807623
28.

Submaximal adenosine-induced coronary hyperaemia with 12 h caffeine abstinence: implications for clinical adenosine perfusion imaging tests.

Carlsson M, Jögi J, Bloch KM, Hedén B, Ekelund U, Ståhlberg F, Arheden H.

Clin Physiol Funct Imaging. 2015 Jan;35(1):49-56. doi: 10.1111/cpf.12125. Epub 2014 Jan 12.

PMID:
24418159
29.

Perfusion SPECT in patients with suspected pulmonary embolism.

Bajc M, Miniati M, Jögi J, Stein PD.

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1432-7. doi: 10.1007/s00259-013-2425-8. Epub 2013 May 8.

PMID:
23653241
30.

Discrimination of ST deviation caused by acute coronary occlusion from normal variants and other abnormal conditions, using computed electrocardiographic imaging based on 12-lead ECG.

Akil S, Al-Mashat M, Hedén B, Hedeer F, Jögi J, Wang JJ, Wagner GS, Warren JW, Pahlm O, Horáček BM.

J Electrocardiol. 2013 May-Jun;46(3):197-203. doi: 10.1016/j.jelectrocard.2013.02.013. Epub 2013 Mar 28.

PMID:
23540511
31.

Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera.

Oddstig J, Hedeer F, Jögi J, Carlsson M, Hindorf C, Engblom H.

J Nucl Cardiol. 2013 Feb;20(1):38-44. doi: 10.1007/s12350-012-9634-6. Epub 2012 Nov 10.

PMID:
23143809
32.

Tomographic ventilation/perfusion lung scintigraphy in the monitoring of the effect of treatment in pulmonary embolism: serial follow-up over a 6-month period.

Begic A, Jögi J, Hadziredzepovic A, Kucukalic-Selimović E, Begovic-Hadzimuratovic S, Bajc M.

Nucl Med Commun. 2011 Jun;32(6):508-14. doi: 10.1097/MNM.0b013e328344dfd5.

PMID:
21403584
33.

Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT.

Jögi J, Ekberg M, Jonson B, Bozovic G, Bajc M.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1344-52. doi: 10.1007/s00259-011-1757-5. Epub 2011 Mar 2.

PMID:
21365251
34.

Ventilation-perfusion SPECT with 99mTc-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease.

Jögi J, Jonson B, Ekberg M, Bajc M.

J Nucl Med. 2010 May;51(5):735-41. doi: 10.2967/jnumed.109.073957. Epub 2010 Apr 15.

35.

Trans-resveratrol alone and hydroxystilbenes of rhubarb (Rheum rhaponticum L.) root reduce liver damage induced by chronic ethanol administration: a comparative study in mice.

Raal A, Pokk P, Arend A, Aunapuu M, Jõgi J, Okva K, Püssa T.

Phytother Res. 2009 Apr;23(4):525-32. doi: 10.1002/ptr.2665.

PMID:
19067386
36.

Heart failure diagnostics based on ventilation/perfusion single photon emission computed tomography pattern and quantitative perfusion gradients.

Jögi J, Palmer J, Jonson B, Bajc M.

Nucl Med Commun. 2008 Aug;29(8):666-73. doi: 10.1097/MNM.0b013e328302cd26.

PMID:
18753817
37.

Profile of sterilized women in urban slums and evaluation of motivational strategies.

Vaidya VG, Sahasrabudhe BG, Jogi JA, Mitkar RP.

Indian J Public Health. 2003 Jan-Mar;47(1):31-3.

PMID:
14723293
38.

Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines.

Garwicz D, Lindmark A, Hellmark T, Gladh M, Jögi J, Gullberg U.

J Leukoc Biol. 1997 Jan;61(1):113-23.

PMID:
9000544

Supplemental Content

Support Center